Samuel Hintermann

Title: Samuel Hintermann: Innovator in Pharmaceutical Chemistry

Introduction

Samuel Hintermann is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases. With a total of 8 patents to his name, Hintermann's work has the potential to impact medical treatments significantly.

Latest Patents

Hintermann's latest patents include innovative compounds such as substituted quinazolin-4-one derivatives. These compounds are designed to treat disorders mediated by the activity of class I PI3K kinases. Another notable patent involves disubstituted heteroaryl-fused pyridines, which are presented in both free and salt forms. These compounds are not only prepared for medicinal use but also incorporated into various medicaments.

Career Highlights

Throughout his career, Samuel Hintermann has worked with leading organizations in the pharmaceutical industry. Notably, he has been associated with Novartis AG, a global healthcare company, and the Sloan-Kettering Institute for Cancer Research, where he has contributed to groundbreaking research and development.

Collaborations

Hintermann has collaborated with esteemed colleagues in his field, including Samuel J. Danishefsky and Dalibor Sames. These partnerships have fostered innovation and have led to advancements in pharmaceutical research.

Conclusion

Samuel Hintermann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for new treatments and advancements in medical science.